Related references
Note: Only part of the references are listed.Aspirin desensitization vs biologics for patients with aspirin-exacerbated respiratory disease
Tanya M. Laidlaw
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)
The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology
Whitney W. Stevens et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Richard R. Orlandi et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2021)
Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade
Christine Bangert et al.
SCIENCE IMMUNOLOGY (2021)
Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma
William W. Busse et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2020)
Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease A Randomized Controlled Trial
Hiroaki Hayashi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease
Sven Schneider et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Prediction of clinical response to omalizumab in moderate-to-severe asthma patients using the change in total serum IgE level
Bohou Li et al.
JOURNAL OF THORACIC DISEASE (2020)
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)a EAACI position paper
Marek L. Kowalski et al.
ALLERGY (2019)
Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD
Masami Taniguchi et al.
ALLERGOLOGY INTERNATIONAL (2019)
Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease
Tiffany Jean et al.
ALLERGY AND ASTHMA PROCEEDINGS (2019)
Omalizumab can inhibit respiratory reaction during aspirin desensitization
David M. Lang et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study
Jeremy Waldram et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Omalizumab for Severe Asthma: Beyond Allergic Asthma
C. C. Loureiro et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
Corrado Pelaia et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2018)
The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change
R. Ertas et al.
ALLERGY (2018)
Aspirin-exacerbated respiratory disease: Mediators and mechanisms of a clinical disease
Katherine N. Cahill et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Aspirin tolerance in patients with nonsteroidal anti-inflammatory druge exacerbated respiratory disease following treatment with omalizumab
Elsa Phillips-Angles et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Comparable actions of omalizumab on mast cells and basophils
E. Serrano-Candelas et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease
Katherine N. Cahill et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2016)
Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease
Hiroaki Hayashi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Local Immunoglobulin E in the Nasal Mucosa: Clinical Implications
Els De Schryver et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2015)
Elevated total serum IgE in nonatopic patients with aspirin-exacerbated respiratory disease
Christina B. Johns et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2014)
Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells
Alexander Eggel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis
Grazyna Bochenek et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Exploring the Effects of Omalizumab in Allergic Asthma An Analysis of Biomarkers in the EXTRA Study
Nicola A. Hanania et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Urinary tetranor-PGDM concentrations in aspirin-intolerant asthma and anaphylaxis
Noritaka Higashi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Specific IgE against Staphylococcus aureus enterotoxins: An independent risk factor for asthma
Claus Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Aspirin-Intolerant Asthma (AIA) Assessment Using the Urinary Biomarkers, Leukotriene E4 (LTE4) and Prostaglandin D2 (PGD2) Metabolites
Noritaka Higashi et al.
ALLERGOLOGY INTERNATIONAL (2012)
Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease
Andrew P. Hope et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Development of a grading scale for the Sino-Nasal Outcome Test-20 German Adapted Version (SNOT-20 GAV)
I. Baumann et al.
HNO (2008)
Quality of life in patients with chronic rhinosinusitis. Validation of the Sino-Nasal Outcome Test-20 German Adapted Version
I. Baumann et al.
HNO (2007)
Rhinosinusitis: Developing guidance for clinical trials
Eli O. Meltzer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
S Holgate et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma
R Djukanovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis
T Van Zele et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20)
JF Piccirillo et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2002)
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
W Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Total and specific IgE in nasal polyps is related to local eosinophilic inflammation
C Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Share Paper
